Business | Racing ahead

A billion-plus covid-19 shots in 2021. Can Serum Institute do it?

The Indian vaccine-maker may account for almost half the world’s supply

|6 min read

ON MARCH 5TH 2020 Mumbai’s horseracing season culminated with the Poonawalla Breeders’ Multimillion, a day-long extravaganza dominated by India’s first family of the sport, the Poonawallas. Triumphs at the track were accompanied by news reports on the Bollywood lifestyles of Adar Poonawalla and his wife, Natasha, whom Elle magazine described as “India’s first lady of fabulousness”. Only cursory attention spilled over to the couple’s day job running Serum Institute of India, the press-shy vaccine-maker at the root of the family fortune.

This article appeared in the Business section of the print edition under the headline “Racing ahead”

The lessons of Fukushima

From the March 6th 2021 edition

Discover stories from this section and more in the list of contents

Explore the edition
A Cognac-maker tastes a sample of Cognac brandy in his cellar.

Pity France’s cognac-makers

They have won a respite from China, but face growing pressures in America

Linda Yaccarino, the CEO of X

Linda Yaccarino goes from X CEO to ex-CEO

The top position at Elon Musk’s social-media platform is open once again


Does working from home kill company culture?

Our analysis suggests it depends on what sort of culture bosses want


On Lego, love and friendship

Human relations are a useful way to think about brands

Jeff Bezos 2.0: new wife, newish job, old vision

The Amazon founder’s semi-retirement plan

Would you pay $19 for a strawberry?

The rise of luxury fruit